Julio Lambea
Impact in
- Otorhinolaryngology top 0.5%
- Head and Neck Cancer Studies
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Renal cell carcinoma treatment 9
-
- Head and Neck Cancer Studies 3
- Co-authors
- Berta Sáez (3 shared papers)Alejandro Tres (3 shared papers)Manuel Arruebo (1 shared paper)África González‐Fernández (1 shared paper)Nuria E. Vilaboa (1 shared paper)Dolores Isla (6 shared papers)Juan Jesús Cruz (2 shared papers)Javier Martínez‐Trufero (2 shared papers)
- Journals
- Cancers (2 papers)Clinical Breast Cancer (1 paper)Therapeutic Advances in Medical Oncology (1 paper)Nature Genetics (1 paper)Current Oncology Reports (1 paper)
- Partner nations
- SpainSwedenNetherlands
In The Last Decade
Julio Lambea
22 papers receiving 2.9k citations
Julio Lambea's Hit Papers
Peers
Comparison fields: 5 of 125
- Otorhinolaryngology 569
- Oncology 1.0k
- Cancer Research 289
- Pulmonary and Respiratory Medicine 449
- Immunology 290
Countries citing papers authored by Julio Lambea
This map shows the geographic impact of Julio Lambea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julio Lambea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julio Lambea more than expected).
Fields of papers citing papers by Julio Lambea
This network shows the impact of papers produced by Julio Lambea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julio Lambea. The network helps show where Julio Lambea may publish in the future.
Co-authors
The 25 scholars most cited alongside Julio Lambea, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study Hit paper breakdown → | 2018 | 1366 |
| 2 | Assessment of the Evolution of Cancer Treatment Therapies Hit paper breakdown → | 2011 | 727 |
| 3 | 2008 | 392 | |
| 4 | 2016 | 82 | |
| 5 | 2021 | 71 | |
| 6 | 2010 | 51 | |
| 7 | 2008 | 46 | |
| 8 | 2021 | 31 | |
| 9 | 2005 | 23 | |
| 10 | 2018 | 21 | |
| 11 | 2017 | 18 | |
| 12 | 2021 | 17 | |
| 13 | 2008 | 14 | |
| 14 | 2021 | 14 | |
| 15 | 2012 | 13 | |
| 16 | 2022 | 13 | |
| 17 | 2016 | 6 | |
| 18 | 2017 | 5 | |
| 19 | 2021 | 3 | |
| 20 | 2005 | 2 |
About Julio Lambea
Julio Lambea is a scholar working on Pulmonary and Respiratory Medicine, Otorhinolaryngology, Oncology, Cancer Research and Physiology, having authored 22 papers that have together received 2.9k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (9 papers), Cancer Genomics and Diagnostics (3 papers), Head and Neck Cancer Studies (3 papers), Nutrition and Health in Aging (3 papers), Immunotherapy and Immune Responses (2 papers), Renal and related cancers (2 papers), Economic and Financial Impacts of Cancer (2 papers) and Cancer Diagnosis and Treatment (2 papers). The work is most often cited by research in Otorhinolaryngology (569 citations), Oncology (1.0k citations), Cancer Research (289 citations), Pulmonary and Respiratory Medicine (449 citations) and Immunology (290 citations). Julio Lambea has collaborated with scholars based in Spain, Sweden and Netherlands. Frequent co-authors include Berta Sáez, Alejandro Tres, Manuel Arruebo, África González‐Fernández, Nuria E. Vilaboa, Dolores Isla, Juan Jesús Cruz, Javier Martínez‐Trufero, Jose Luis González Larriba and Ignacio Durán. Their work appears in journals such as Cancers, Clinical Breast Cancer, Therapeutic Advances in Medical Oncology, Nature Genetics and Current Oncology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.